We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$594M
AUM Growth
-$36.3M
Cap. Flow
+$29.2M
Cap. Flow %
4.91%
Top 10 Hldgs %
93.96%
Holding
13
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MRSN
Mersana Therapeutics
MRSN
+$16.4M
2
CNTX icon
Context Therapeutics
CNTX
+$12.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.2B
$244M 41.11%
6,296,740
– –
TYRA icon
2
Tyra Biosciences
TYRA
$1.82B
$64.9M 10.91%
4,055,861
– –
TNGX icon
3
Tango Therapeutics
TNGX
$4.17B
$47.5M 7.99%
5,533,980
– –
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
$43.4M 7.3%
2,642,502
– –
ARVN icon
5
Arvinas
ARVN
$525M
$37.5M 6.31%
1,408,394
– –
ORIC icon
6
Oric Pharmaceuticals
ORIC
$1.18B
$37.4M 6.29%
5,285,714
– –
RLAY icon
7
Relay Therapeutics
RLAY
$3.94B
$25.1M 4.22%
3,846,409
– –
CGEM icon
8
Cullinan Oncology
CGEM
$1.03B
$21.3M 3.58%
1,221,145
– –
MRSN
9
DELISTED
Mersana Therapeutics
MRSN
$19.1M 3.22%
381,046
+226,793
+147% +$16.4M
SLN
10
Silence Therapeutics
SLN
$537M
$18.1M 3.04%
952,400
– –
SPRY icon
11
ARS Pharmaceuticals
SPRY
$552M
$16.3M 2.73%
1,910,029
– –
CNTX icon
12
Context Therapeutics
CNTX
$53.7M
$14.9M 2.5%
+7,419,355
New +$12.8M
BOLD
13
Boundless Bio
BOLD
$55.7M
$4.75M 0.8%
1,228,069
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q2 2024 Portfolio in Review

As of Q2 2024, Nextech Invest held 13 positions worth $594M, down 5.8% from $631M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Nextech Invest deployed $29.2M of net new capital in Q2 2024, opening 1 new position and adding to 1 existing holding. Its largest new stake was Context Therapeutics: 7,419,355 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Nextech Invest's largest Q2 2024 buy was Context Therapeutics: 7,419,355 shares worth $14.9M.
  • Nextech Invest added most to Mersana Therapeutics in Q2 2024, an estimated $16.4M increase.
  • Nextech Invest's ten largest holdings make up 94% of its $594M portfolio in Q2 2024.
  • Nextech Invest opened 1 new position and closed 0 in Q2 2024.
  • Nextech Invest's portfolio value fell 5.8% quarter-over-quarter to $594M.

Based on Nextech Invest's 13F filing for Q2 2024, filed 14 Aug 2024.